Sociodemographic predictors of delayed- versus early-stage cervical cancer in California

Annals of Epidemiology

Volumn 25, Issue 4, 2015, Pages 250-255

  Saghari, Sepideh ^a   Ghamsary, Mark ^a   Marie Mitchell, Ariane ^a   Oda, Keiji ^a   Morgan, John W ^a,b  

^a LOMA LINDA UNIVERSITY   (United States)

^b Desert Sierra Cancer Surveillance Program   (United States)

Author keywords

Cancer; Delayed stage; Demographic; Ethnicity; Marital status; Race; Race ethnicity; SES; Socioeconomic status

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BASAL CELL CARCINOMA; BLACK PERSON; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CAUCASIAN; DEMOGRAPHY; ENDOMETRIUM CARCINOMA; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MARRIED WOMAN; MIDDLE AGED; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE; SOCIAL STATUS; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERUS SARCOMA; YOUNG ADULT; AGE; ANCESTRY GROUP; DELAYED DIAGNOSIS; REGISTER; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS;

ADULT; AGE FACTORS; AGED; CALIFORNIA; CONTINENTAL POPULATION GROUPS; DELAYED DIAGNOSIS; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MARITAL STATUS; MIDDLE AGED; REGISTRIES; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84925202765     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2015.01.008     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M., Ferlay J., Wars E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Siegel R.L., Miller K.D., Jamal A. Cancer statistics. CA Cancer J Clin 2015, 65:5-209.
3. Howlader N., Noone A.M., Krapcho M., Garshell J., Neyman N., Altekruse S.F., et al. SEER cancer statistics review, 1975-2010 2013, National Cancer Institute, Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2010/.
4. Schiffman M., Wentzensen N., Wacholder S., Kinney W., Gage J.C., Castle P.E. Human papillomavirus testing in the prevention of cervical cancer. JNatl Cancer Inst 2011, 103(5):368-383.
5. Clifford G.M., Smith J.S., Plummer M., Muñoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88(1):63-73.
6. Green J., Berrington de Gonzalez A., Sweetland S., Beral V., Chilvers C., Crossley B., et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003, 89(11):2078-2086.
7. Clinical review of biologics license application for human papillomavirus 6, 11, 16, 18, L1 virus like particle vaccine (S.cerevisiae). (STN 125126 GARDASIL) 2006, US Food and Drug Administration, Merck Inc, Kenilworth, NJ.
8. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):626-629. Centers for Disease Control and Prevention (CDC).
9. Castellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. JNatl Cancer Inst 2006, 98(5):303-315. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
10. Karanam B., Jagu S., Huh W.K., Roden R.B. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunol Cell Biol 2009, 87(4):287-299.
11. Wilyman J. HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery. Infect Agent Cancer 2013, 8(1):21.
12. Dochez C., Bogers J.J., Verhelst R., Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine 2014, 32(14):1595-1601.
13. Kulasingam SL, Havrilesky L, Ghebre R, Myers ER. Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force [Internet]. Rockville (MD) Agency Healthc Res Qual (US); May 2011. (Evidence Syntheses, No. 86s.) Available at: http://www.ncbi.nlm.nih.gov/books/NBK92546/.
14. Garner E.I. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 2003, 12(3):242s-247s.
15. United States cancer statistics: 1999-2010 incidence and mortality web-based report 2009, US Cancer Statistics Working Group, US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA, Available at:. http://www.cdc.gov/uscs.
16. Benard V.B., Eheman C.R., Lawson H.W., Blackman D.K., Anderson C., Helsel W., et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol 2004, 103(3):564-571.
17. Tangka F.K., O'Hara B., Gardner J.G., Turner J., Royalty J., Shaw K., et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control 2010, 21(7):1081-1090.
18. Cancer Facts & Figures2014 2014, American Cancer Society, Atlanta, GA.
19. SEER cancer statistics review, 1975-2011 2014, National Cancer Institute, Bethesda, MD, based on November 2013 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2011/, N. Howlader, A.M. Noone, M. Krapcho, J. Garshell, D. Miller, S.F. Altekruse (Eds.).
20. Ferrante J.M., Gonzalez E.C., Roetzheim R.G., Pal N., Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med 2000, 9(5):439-445.
21. Fedewa S.A., Cokkinides V., Virgo K.S., Bandi P., Saslow D., Ward E.M. Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. Am J Public Health 2012, 102(9):1782-1790.
22. McCarthy A.M., Dumanovsky T., Visvanathan K., Kahn A.R., Schymura M.J. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control 2010, 21(10):1645-1655.
23. Eggleston K.S., Coker A.L., Williams M., Tortolero-Luna G., Martin J.B., Tortolero S.R. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995-2001. JWomens Health (Larchmt) 2006, 15(8):941-951.
24. Simard E., Fedewa S., Ma J., Siegel R., Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer 2012, 118:5110-5116.
25. California Cancer Registry. Accessed November 27,2014. http://www.ccrcal.org/.
26. Yost K., Perkins C., Cohen R., Morris C., Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001, 12:703-711.
27. Morgan J.W., Cho M.M., Guenzi C.D., Jackson C., Mathur A., Natto Z., et al. Predictors of delayed-stage colorectal cancer: are we neglecting critical demographic information?. Ann Epidemiol 2011, 21(12):914-921.
28. International classification of diseases for oncology 2000, World Health Organization, Geneva. 3rd ed. A. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, M. Parkin, et al. (Eds.).
29. Greene F.L. American Cancer S. AJCC cancer staging handbook: from the AJCC cancer staging manual 2002, American Joint Committee on Cancer Staging, Springer, New York, NY.
30. Collaborative staging manual and coding instructions, version1.0 2004, Collaborative Staging Task Force of the American Joint Committee on Cancer, Jointly published by, American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services, Bethesda, MD, NIH Publication Number 04-5496.
31. Surveillance Research Program, National Cancer Institute SEER*Stat software, version 8.0.4. Information available on July 23,2014. http://www.seer.cancer.gov/seerstat.
32. SAS Institute, Cary, NC) (SAS [computer program]. Version 9.3 2008, SAS, SAS Institute, Cary, NC, Information available on the Internet at, [accessed 6.2.20]. http://www.sas.com/?gclid=CMmA3buwmqcCFRtVgwod5V28eg.
33. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012, 62:147-172.
34. Saint M., Gildengorin G., Sawaya G.F. Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol 2005, 192(2):414-421.
35. Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004, 101(5):1051-1057.
36. Goodwin J.S., Hunt W.C., Key C.R., Samet J.M. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987, 258(21):3125-3130.